ArticleOncology letters2023
Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment.
Ahmet Bilgehan Sahin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it